Insider Transactions in Q2 2025 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
828
+0.89%
|
-
|
|
Jun 30
2025
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
1,471
+6.21%
|
-
|
|
Jun 30
2025
|
Elizabeth H.Z. Thompson |
BUY
Grant, award, or other acquisition
|
Direct |
694
+8.8%
|
-
|
|
Jun 30
2025
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
1,284
+2.31%
|
-
|
|
Jun 30
2025
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,906
+0.15%
|
-
|
|
Jun 30
2025
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
828
+0.03%
|
-
|
|
Jun 30
2025
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
828
+6.12%
|
-
|
|
Jun 16
2025
|
Mary Beth Harler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,522
-0.45%
|
$1,522
$1.2 P/Share
|
|
Jun 16
2025
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,522
-0.84%
|
$1,522
$1.2 P/Share
|
|
Jun 16
2025
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
486
-1.8%
|
$486
$1.2 P/Share
|
|
Jun 16
2025
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
951
-1.29%
|
$951
$1.2 P/Share
|
|
May 14
2025
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,865
-6.46%
|
$1,865
$1.12 P/Share
|